Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1832312 | 0.76 | NR1I2 (0.44) | — | |
| SCHEMBL19179640 | 0.76 | NR1I2 (0.44) | — | |
| SCHEMBL1813435 | 0.74 | HSD11B1 (0.37) | — | |
| SCHEMBL1816434 | 0.74 | PGR (0.40) | — | |
| SCHEMBL2361267 | 0.73 | BRD4 (0.31) | — | |
| SCHEMBL3423035 | 0.72 | ALDH1A1 (0.37) | HTR7 | |
| SCHEMBL8802786 | 0.71 | ALDH1A1 (0.38) | — | |
| SCHEMBL15791947 | 0.70 | HTR7 (0.36) | HTR7CYP11B2 | |
| SCHEMBL1812412 | 0.69 | NR1H2 (0.43) | — | |
| SCHEMBL1814835 | 0.69 | ALDH1A1 (0.41) | HTR7CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2318358-A2 | ACYLAMINOBENZAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2011-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | KCNB1, KCNA5, KCNA7 | HTR7 464/4885CYP11B2 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.